Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PEPD | P12955 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13952183 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL791505 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL265072 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL10556768 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL3382944 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL265657 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL9885352 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL11930055 | 1.00 | EPHX1 (0.62) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL6917395 | 0.97 | EPHX1 (0.60) | EPHX1CA1CA2CA4MEN1 | |
| SCHEMBL12529955 | 0.97 | EPHX1 (0.60) | EPHX1CA1CA2CA4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 704 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-118661881-A | 6-Methyl nicotine salt preparation and preparation method thereof, buccal product, atomization matrix and electronic atomization device | 爱奇迹创造有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| CN-115502075-A | Construction method of high-temperature-resistant heat-conducting anticorrosive coating | 中国石油化工股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-114621727-A | Low-density high-flame-retardant epoxy structural adhesive for bonding battery module and preparation method thereof | 湖南广信科技发展有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-110483992-B | Low-warpage reinforced semi-aromatic high-temperature nylon composite material and preparation method thereof | 株洲时代新材料科技股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-106674172-B | Method for preparing hexahydrophthalic anhydride | 大连理工大学 | 2020-02-21 | — | — | CN | claimed |
| CN-108729226-A | A kind of preparation method of rapid-curing cutback raincoat cloth | 枞阳县陶波雨具有限公司 | 2018-11-02 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| EP-1655372-A2 | Production of polyketides and other natural products | Biotica Technology Limited (GB) | 2006-05-10 | — | — | EP | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20050272132-A1 | Production of polyketides and other natural products | BIOTICA TECHNOLOGY LIMITED (GB) | 2005-12-08 | — | — | US | claimed |
| EP-1589031-A2 | Production of polyketides and other natural products | Biotica Technology Limited (GB) | 2005-10-26 | — | — | EP | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0468470-B1 | Benzimidazoles, medicaments containing them and process for their preparation | THOMAE GMBH DR K (DE) | 1997-04-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | EPHX1 1402/4885CA1 4047/4885CA2 3509/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | EPHX1 3259/4885CA1 102/4885CA2 32/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | EPHX1 2835/4885CA1 139/4885CA2 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.